Deepcell Expands Leadership Team to Shape the Future of Cell Morphology
Summary
Marc Montserrat joins as Chief Business Officer of Deepcell, bringing two decades of experience at successful therapeutics, diagnostics and life sciences companies, including Roche and Genentech. The company also announced that Matt Posard, a 30-year life sciences industry veteran and former Illumina executive, will guide Deepcell’s leadership team as Chief Strategist, providing strategic guidance and executive-level support. In his new role as CBO, Marc Montserrat is responsible for managing the company’s business development and providing leadership to create value for customers, partners and investors through strategic alignment and cross-functional execution. Their knowledge and collective experience will be highly valuable in bringing our AI-powered innovation to market and engaging with the life science and biomedical community to maximize the potential of our unique technology platform.” For more information about Deepcell, please go to www.deepcell.com. Spun out of Stanford University in 2017, the company has created unique, microfluidics-based technology that uses continuously learning AI to classify cells based on detailed visual features and sort them without inherent bias.